| |
|
|
|
|
| October 29 ,
2009 | ISSUE NUMBER 122 VOL 6 |
Government
GAO Accuses FDA of Tardy Trial Data
The US oversight arm scripted a hefty report complaining that FDA is not moving fast enough when it comes to screening clinical trials data for drugs green lit through its expedited approval program.
Social Media
Sidewiki: What’s Pharma to Do?
Google opened up a whole new era of social media when it released Sidewiki—a tool that allows anyone to comment on any Web site. Now pharma has a new dilemma—how can it stop consumers from posting false and off label information? Benjamin Curtis gives some advice on how pharma can sidestep Sidewiki.
Warning Letter
Sanofi Warned for Misleading Tent Card
Sure, prescription information for Sanofi-Aventis’s Uroxatral appears on the back of the tent card, but how can consumer’s see it if it’s mounted to a pharmacy wall?
Events
Connect with a Click of the Mouse
Thanks to Google, Facebook, and Twitter, the Internet has become the e-Patient’s No. 1 destination for seeking health information, and industry was all “a tweet” about it at this year’s e-Patient Connections Conference.
Global
Go Easy on Your Pharma Lobbyists
European pharmaceutical executives are sometimes heard to complain that their public affairs departments are not doing a good job for them, and that their industry associations are a waste of time and money.
Guest Blog
If Not This, Then What? If Not Now, Then When?
I’ve been an avid runner for a long time. A while back, I had an injury that just wasn’t responding to any of the methods that I had used for years. And yet, I was reluctant to change anything.
Podcast
Emerging Pharma Leadership Awards–Kathryn Metcalfe
“The current economic environment is forcing the industry to adapt and change for the better in order to survive. I believe this will result in survival of the fittest, and biotech will be a source of pride and innovation in the US for decades to come.” Listen to the Podcast for more coverage.
New & Noteworthy
Finding the Sweet Spot
How proper site activation and site enrollment can help you get the most from clinical trials. |
 |
 |
|  Impact Unlimited won three Gold Awards at the 35th Annual Jasper Awards in New Jersey // AbelsonTaylor promoted Lindsey Goniu to copywriter and Jennie Skrzypczynski to associate copywriter
// EvoLogue made Justin Harrington executive vice president, director of client services
// Wolters Kluwer Health appointed Karen Overstreet, M.D., executive director to run the Lippincott CME Institute // Medivation appointed Hank Mansbach, M.D., to vice president of medical affairs
// WuXi PharmaTech made Hui Cai, M.D., vice president of business development // NGM Biopharmaceuticals appointed Arthur D. Levinson to its board of directors
// Santaris Pharma A/S appointed Mark Wedel, M.D., vice president and chief medical officer and Stuart Mackey, as vice president strategy and chief business officer
// Cephalon hired Bob Repella as senior vice president, US Pharmaceutical Operations
// Sorrento Therapeutics made Martina Molsbergen vice president, business development
//
|
Advertisement:
Rich opportunities for your clinical trials are emerging increasingly in non-traditional markets. But diverse regulatory requirements and varying timelines may be keeping you from exploring opportunities in these regions. How can you realize the potential recruitment advantages, cost-savings and efficiencies?  Watch our webcast to hear five Quintiles experts share insights to help you navigate the global regulatory landscape — and find your new development edge.
|
December 2 Risk, Reward and the Pharmaceutical Life Cycle: Managing Information as a Strategic Productivity Asset
Wednesday, December 2, 2009 at 11AM ET
|
Nov 9–10, 2009 Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders,
Princeton, NJ
Nov 17–18, 2009 3rd Annual Evidence-Based Medicine and Comparative Effectiveness Research Summit for the Bio/Pharmaceutical and Medical Device Industries,
Philadelphia, PA
Dec 8–9, 2009 Forum on FDA’s Structured Product Labeling, Washington, DC
Jan 21–22, 2010 Bio/Pharmaceutical Forum on Optimizing the Use of Complex Data Assets,
Philadelphia, PA
Jan 25–26, 2010 Bio/Pharmaceutical Forum on Strategic Sourcing and Procurement,
Philadelphia, PA
Feb 8–9, 2010 3rd Annual Clinical Trial Forecasting and Budgeting, Philadelphia, PA
|
|
|
|
 |
|
 |
|
 |
| Is your pharmaceutical company planning on upgrading its operating system in the next year? |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
